PharmaVault
گنجینه اطلاعات داروسازی
The Pharmaceutical Information Vault
Excipient monograph · مونوگراف ماده جانبی
pharmavault.ir
Polydextrose
پلیدکستروز
1Nonproprietary names
- USP–NFPolydextrose
2Synonyms and trade names
Litesse; polydextrosum; Sta-Lite; E1200
3Chemical name and CAS Registry Number
Randomly bonded condensation polymer of D-glucose with minor amounts of sorbitol and citric acid · [68424-04-4]
4Empirical formula and molecular weight
(C6H10O5)n
5Functional category
Diluent (filler)
Typical concentrations: — · Dosage forms: Solid
6Applications in pharmaceutical formulation
In foods polydextrose is used as a low-calorie bulking agent, humectant and source of soluble dietary fibre, replacing sugar and fat. In pharmaceuticals it is used as a bulking agent and binder in tablets, in chewable and sugar-free formulations, and as a component of film coatings. Use levels depend widely on the function, from a few percent as a binder to a major part of the formulation as a bulking agent.
7Description
A white to light cream, amorphous, hygroscopic powder that is almost odourless and has a neutral to slightly tart taste; it is not sweet. It is a polydisperse polymer with a wide molecular-weight distribution and only a small fraction of free glucose and sorbitol.
8Typical properties
- Composition
- approximately 90% glucose, 10% sorbitol and 1% citric acid (by weight, before polymerisation); 1→6 glycosidic bonds predominate
- Energy value
- about 1 kcal/g (≈ 4 kJ/g)
- Solubility
- very soluble in water (solutions of about 80% w/w can be made); limited solubility in ethanol
- pH
- 2.5–7.0 (10% w/v solution), depending on whether the grade has been neutralised
- Hygroscopicity
- hygroscopic amorphous powder
9Stability and storage conditions
Stable under normal conditions but hygroscopic; it absorbs moisture and may cake when exposed to humid air. Store in a well-closed container in a cool, dry place.
10Incompatibilities
Incompatible with strong oxidising agents. The acidic unneutralised grades may affect acid-sensitive drugs, and residual reducing end groups can give some browning with amines on heating.
11Method of manufacture
Made by heating a melt of glucose with about 10% sorbitol and 1% citric acid under vacuum, which causes random polycondensation; the product may then be purified and neutralised (for example with potassium hydroxide) and dried.
12Safety
Polydextrose is only partly fermented in the colon and is regarded as non-toxic. Like other poorly digested carbohydrates, large single doses can cause a laxative effect and flatulence. JECFA has not specified an ADI.
13Handling precautions
Observe normal precautions for the quantity handled. Avoid dust generation; eye protection and gloves are recommended.
14Regulatory status
Approved in the USA as a direct food additive and accepted as a food additive in Europe (E1200). Used in oral pharmaceutical products.
15Related substances
Dextrin; inulin; maltodextrin.
16Comments
Because it is not sweet, polydextrose is usually combined with an intense sweetener in sugar-free products. Its hygroscopicity should be considered when it is used in solid dosage forms, and low-moisture packaging may be needed.